ImClone Systems, Inc. (IMCL)

TMFPeterJ (< 20) Submitted: 8/28/06 5:14 PM : Start Price: $34.94 IMCL Score: -6.02

You hate to vote against stock in a company doing something as vital as cancer research. But IMCL's track record suggests its research could produce better results in the hands of a more well-run biotech.

Report this Post Replies: 2 | Reply | Permalink

NetscribeBiotech (66.48) Submitted: 3/12/07 5:11 AM : Start Price: $28.90 IMCL Score: 42.76

ImClone Systems Incorporated (ImClone) is a biopharmaceutical company that is focused on development of oncology therapeutics. With various drugs in the pipeline, addressing the medical needs of patients affected with cancer, the company’s only comme...

Report this Post Replies: 1 | Reply | Permalink

wundermichl (34.37) Submitted: 5/13/08 12:14 PM : Start Price: $43.03 IMCL Score: -4.83

Cetuximab (Erbitux) will most likely be approved for treatment of non-small cell lung cancer. The recent downgrade by a Morgan Stanley analyst was probably derived from speculation and not actual data of the FLEX study. Extrapolating data from the ...

Report this Post Replies: 1 | Reply | Permalink

chintu30 (86.87) Submitted: 10/09/07 12:42 PM : Start Price: $43.79 IMCL Score: 3.45

Many FDA approvals pending

Report this Post Replies: 0 | Reply | Permalink

tiobueno (21.95) Submitted: 9/21/07 1:35 PM : Start Price: $42.70 IMCL Score: 4.29

Insider (secform4.com)

Report this Post Replies: 0 | Reply | Permalink

mimosapartners (72.35) Submitted: 9/18/07 4:02 PM : Start Price: $41.73 IMCL Score: 6.98

Erbitux.

Report this Post Replies: 0 | Reply | Permalink

chelstad (< 20) Submitted: 9/11/07 2:36 PM : Start Price: $45.69 IMCL Score: -5.51

CEO bought in

Report this Post Replies: 0 | Reply | Permalink

farhawk (< 20) Submitted: 7/06/07 12:33 PM : Start Price: $37.07 IMCL Score: 19.00

Putting in a bottom here.

Report this Post Replies: 0 | Reply | Permalink

SapphireSeas (80.28) Submitted: 6/01/07 2:02 PM : Start Price: $41.51 IMCL Score: 7.82

One word - Erbitrux (hope I spelled that right). ImClone still building on early success, and clinicals are promising for even more potent oncology applications to come.

Report this Post Replies: 0 | Reply | Permalink

benoitlj (95.32) Submitted: 4/20/07 7:51 PM : Start Price: $42.02 IMCL Score: 3.13

Erbitux will be shown to be effective in treatment of lung cancer vastly increasing the number of patients who can use it.

Report this Post Replies: 0 | Reply | Permalink